Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,234 | 16 | 97.3% |
| Education | $34.12 | 1 | 2.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| JAZZ PHARMACEUTICALS INC. | $337.89 | 3 | $0 (2019) |
| Avanir Pharmaceuticals, Inc. | $219.22 | 2 | $0 (2017) |
| Mallinckrodt LLC | $127.89 | 2 | $0 (2017) |
| Stryker Corporation | $123.37 | 1 | $0 (2020) |
| Harmony Biosciences LLC | $122.94 | 1 | $0 (2020) |
| UCB, Inc. | $100.01 | 2 | $0 (2017) |
| Lilly USA, LLC | $80.17 | 1 | $0 (2018) |
| Depomed, Inc. | $56.64 | 1 | $0 (2017) |
| ABBVIE INC. | $41.20 | 2 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $34.12 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $41.20 | 2 | ABBVIE INC. ($41.20) |
| 2023 | $34.12 | 1 | Alexion Pharmaceuticals, Inc. ($34.12) |
| 2021 | $24.68 | 1 | Innovation Technologies Inc ($24.68) |
| 2020 | $246.31 | 2 | Stryker Corporation ($123.37) |
| 2019 | $127.36 | 1 | JAZZ PHARMACEUTICALS INC. ($127.36) |
| 2018 | $175.70 | 2 | Jazz Pharmaceuticals Inc. ($95.53) |
| 2017 | $618.76 | 8 | Avanir Pharmaceuticals, Inc. ($219.22) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/27/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $26.79 | General |
| Category: NEUROSCIENCE | ||||||
| 02/09/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: NEUROSCIENCE | ||||||
| 02/15/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Education | In-kind items and services | $34.12 | General |
| Category: Rare Disease | ||||||
| 12/31/2021 | Innovation Technologies Inc | Irrisept (Device) | Food and Beverage | Cash or cash equivalent | $24.68 | General |
| Category: Jet Lavage Device with CHG | ||||||
| 10/02/2020 | Stryker Corporation | MOJAVE (Device) | Food and Beverage | Cash or cash equivalent | $123.37 | General |
| Category: SPINE | ||||||
| 02/18/2020 | Harmony Biosciences LLC | Wakix (Drug) | Food and Beverage | Cash or cash equivalent | $122.94 | General |
| Category: Neurological Disorders | ||||||
| 09/13/2019 | JAZZ PHARMACEUTICALS INC. | XYREM (Drug) | Food and Beverage | Cash or cash equivalent | $127.36 | General |
| Category: NEUROLOGY | ||||||
| 12/11/2018 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $80.17 | General |
| 02/23/2018 | Jazz Pharmaceuticals Inc. | Xyrem (Drug) | Food and Beverage | In-kind items and services | $95.53 | General |
| Category: Neurology | ||||||
| 06/14/2017 | Mallinckrodt LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $123.36 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 05/11/2017 | Jazz Pharmaceuticals Inc. | Xyrem (Drug) | Food and Beverage | In-kind items and services | $115.00 | General |
| Category: Neurology | ||||||
| 04/11/2017 | Avanir Pharmaceuticals, Inc. | ONZETRA Xsail (Drug) | Food and Beverage | In-kind items and services | $119.17 | General |
| Category: Migraine | ||||||
| 03/13/2017 | Avanir Pharmaceuticals, Inc. | ONZETRA Xsail (Drug) | Food and Beverage | In-kind items and services | $100.05 | General |
| Category: Migraine | ||||||
| 01/26/2017 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $93.01 | General |
| Category: Neurology | ||||||
| 01/26/2017 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $7.00 | General |
| Category: Neurology | ||||||
| 01/19/2017 | Depomed, Inc. | Cambia (Drug) | Food and Beverage | In-kind items and services | $56.64 | General |
| Category: Neurology | ||||||
| 01/18/2017 | Mallinckrodt LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $4.53 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 146 | 224 | $37,753 | $12,830 |
| 2022 | 5 | 191 | 284 | $50,523 | $16,924 |
| 2021 | 9 | 199 | 262 | $52,490 | $18,433 |
| 2020 | 7 | 219 | 278 | $63,303 | $20,774 |
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 61 | 88 | $13,112 | $5,166 | 39.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $5,882 | $2,063 | 35.1% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2023 | 34 | 60 | $9,000 | $2,026 | 22.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 18 | 42 | $5,985 | $2,003 | 33.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 16 | 17 | $3,774 | $1,573 | 41.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 65 | 103 | $15,347 | $5,868 | 38.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 26 | 26 | $8,996 | $2,458 | 27.3% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2022 | 32 | 65 | $9,750 | $2,338 | 24.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 25 | 26 | $5,772 | $2,301 | 39.9% |
| 95913 | Nerve conduction, 13 or more studies | Facility | 2022 | 13 | 13 | $3,172 | $1,925 | 60.7% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 19 | 34 | $5,100 | $1,237 | 24.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 11 | 17 | $2,386 | $796.61 | 33.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 44 | 76 | $11,324 | $4,998 | 44.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 33 | 33 | $11,220 | $3,548 | 31.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 26 | 26 | $8,996 | $3,310 | 36.8% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 18 | 40 | $6,000 | $1,467 | 24.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 13 | 14 | $3,108 | $1,438 | 46.3% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 17 | 17 | $4,267 | $1,278 | 29.9% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Facility | 2021 | 19 | 20 | $3,220 | $838.65 | 26.0% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 18 | 23 | $2,015 | $816.82 | 40.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 11 | 13 | $2,340 | $738.79 | 31.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 79 | 82 | $27,880 | $8,977 | 32.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 35 | 50 | $7,286 | $2,661 | 36.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 29 | 41 | $7,380 | $2,287 | 31.0% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 15 | 15 | $6,300 | $2,176 | 34.5% |
About Dr. Avinash Aggarwal, M.D
Dr. Avinash Aggarwal, M.D is a Epilepsy healthcare provider based in Pittsburgh, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/08/2005. The National Provider Identifier (NPI) number assigned to this provider is 1689655581.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Avinash Aggarwal, M.D has received a total of $1,268 in payments from pharmaceutical and medical device companies, with $41.20 received in 2024. These payments were reported across 17 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($1,234).
As a Medicare-enrolled provider, Aggarwal has provided services to 755 Medicare beneficiaries, totaling 1,048 services with total Medicare billing of $68,961. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Practice Information
- Specialty Epilepsy
- Other Specialties Neuromuscular Medicine, Clinical Neurophysiology
- Location Pittsburgh, PA
- Active Since 11/08/2005
- Last Updated 10/07/2024
- Taxonomy Code 2084E0001X
- Entity Type Individual
- NPI Number 1689655581
Products in Payments
- ONZETRA Xsail (Drug) $219.22
- Xyrem (Drug) $210.53
- ACTHAR (Biological) $127.89
- XYREM (Drug) $127.36
- MOJAVE (Device) $123.37
- Wakix (Drug) $122.94
- Briviact (Drug) $100.01
- Cambia (Drug) $56.64
- UBRELVY (Drug) $41.20
- ULTOMIRIS (Biological) $34.12
- Irrisept (Device) $24.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Epilepsy Doctors in Pittsburgh
Thandar Aung, M.d, M.D
Epilepsy — Payments: $13,060
Dr. Joanna Fong-Isariyawongse, M.d, M.D
Epilepsy — Payments: $1,739
Maria Baldwin, Md, MD
Epilepsy — Payments: $215.85
Rahiwa Gebre, Md, MD
Epilepsy — Payments: $187.74
Vijayalakshmi Rajasekaran, M.d.,, M.D.,
Epilepsy — Payments: $186.21
Rafeed Alkawadri, Md, MD
Epilepsy — Payments: $96.12